Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum DisorderTetsuya Akaishi, Ichiro Nakashima, Toshiyuki Takahashi et al.|Neurology|2021Cited by 90
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disordersTetsuya Akaishi, Ichiro Nakashima, Toshiyuki Takahashi et al.|Scientific Reports|2020Cited by 71
Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrenceTetsuya Akaishi, Masashi Aoki, Ichiro Nakashima et al.|Neurology Neuroimmunology & Neuroinflammation|2019Cited by 60
Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD)Tetsuya Akaishi, Kazuo Fujihara, Toshiyuki Takahashi et al.|Journal of the Neurological Sciences|2020Cited by 57
Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSDTetsuya Akaishi, Ichiro Nakashima, Takayuki Takeshita et al.|Frontiers in Neurology|2020Cited by 48